Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening

NCT ID: NCT00977392

Last Updated: 2013-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-06-30

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

RATIONALE: Women who do not undergo routine cervical screening may be more likely to collect a self-sample for human papillomavirus testing.

PURPOSE: This randomized clinical trial is studying self-sampling in women who do not undergo routine cervical screening.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

* To ascertain whether women who do not attend for cervical screening are more likely to respond to the opportunity to collect a self-sample for human papillomavirus (HPV) testing, or to respond to a further invitation to undergo a cervical smear.
* To ascertain whether such women will attend for further investigation if they have a positive screening test (HPV test or cervical smear).

OUTLINE: Patients are randomized to 1 of 2 arms.

* Control: Patients receive an invitation for a routine cervical smear and a cervical screening survey. Information regarding attendance for smear or colposcopy is collected at the Primary Care Trust.
* Study (self-sampling kit): Patients receive an explanatory letter, an information sheet about the study, a consent form, information about human papillomavirus (HPV) and HPV testing, a self-sampling test kit, and an invitation to take their own HPV sample and return it to the research group for processing. Patients also receive a cervical screening survey. Patients who attend for further investigation following a positive HPV result go to St. Mary's Hospital Colposcopy Unit, Paddington. During this visit cervical smear tests are performed and women are offered immediate colposcopy so that they would not need to return for colposcopic examination if their smear test is abnormal.

This study is peer reviewed and funded or endorsed by cancer research UK.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Status Unknown Precancerous Condition

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

human papilloma virus infection health status unknown

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

compliance monitoring

Intervention Type BEHAVIORAL

cervical Papanicolaou test

Intervention Type OTHER

educational intervention

Intervention Type OTHER

screening questionnaire administration

Intervention Type OTHER

survey administration

Intervention Type OTHER

colposcopy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No women who have written to the PCT to document their refusal to take part in the National Health Service Cervical Screening Program (NHSCSP)
* No women who are not due for routine screening as part of the NHSCSP

PATIENT CHARACTERISTICS:

* Not pregnant
* Have been sexually active

PRIOR CONCURRENT THERAPY:

* No prior total abdominal hysterectomy
Minimum Eligible Age

25 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Barts and the London School of Medicine and Dentistry

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anne Szarewski, MD

Role: PRINCIPAL_INVESTIGATOR

Queen Mary University of London

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Barts and the London School of Medicine

London, England, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

http://www.ncbi.nlm.nih.gov/pubmed/21343937

HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Cancer. 2011 Mar 15;104(6):915-20. doi: 10.1038/bjc.2011.48. Epub 2011 Feb 22.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CDR0000648274

Identifier Type: REGISTRY

Identifier Source: secondary_id

ISRCTN40182307

Identifier Type: REGISTRY

Identifier Source: secondary_id

EU-20963

Identifier Type: -

Identifier Source: secondary_id

CRUK-Westminster-Self-Sampling

Identifier Type: -

Identifier Source: org_study_id